Clinical Outcomes of an Innovative Cefazolin Delivery Program for MSSA Infections in OPAT

Cefazolin is a recommended treatment for methicillin-susceptible Staphylococcus aureus (MSSA) infections that has been successfully used in outpatient parenteral antibiotic therapy (OPAT) programs. The aim of this study was to assess the clinical outcomes of cefazolin delivered each day (Group 24) v...

Descripción completa

Detalles Bibliográficos
Autores principales: Herrera-Hidalgo, Laura, Luque-Márquez, Rafael, de Alarcon, Aristides, Guisado-Gil, Ana Belén, Gutierrez-Gutierrez, Belen, Navarro-Amuedo, Maria Dolores, Praena-Segovia, Julia, Carmona-Caballero, Juan Manuel, Fraile-Ramos, Elena, Gutierrez-Valencia, Alicia, Lopez-Cortes, Luis Eduardo, Gil-Navarro, Maria Victoria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950875/
https://www.ncbi.nlm.nih.gov/pubmed/35329878
http://dx.doi.org/10.3390/jcm11061551

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950875/
https://www.ncbi.nlm.nih.gov/pubmed/35329878
http://dx.doi.org/10.3390/jcm11061551

Ejemplares similares